AWAnna E. Garcia Whitlock

Anna E. Garcia Whitlock

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anna E. Garcia Whitlock has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Using geographic information systems to identify Stop the Bleed training locations

    by Anna E Garcia Whitlock, Daniela Schmulevich, Elinore J Kaufman, Justin S Hatchimonji, Karina M Hiroshige, Mark J Seamon, Daniel N Holena, John J Gallagher, Patrick M Reilly, Jeremy W Cannon, et al.

    Objectives: The Stop the Bleed (STB) Campaign seeks to minimize preventable deaths from hemorrhage by educating community members on how to respond to life-threatening bleeding. A persistent challenge is connecting the training to individuals most at risk of witnessing a bleeding event. We hypothesize that geographic information system (GIS) software can identify STB training locations in at-risk communities and that trained individuals will be willing to respond to a bleeding event. Methods: Publicly available shooting locations in a large urban city with a high violent crime rate were assessed for spatial clustering using ArcGIS to map “hot spots.” Community training locations were colocalized on this map to identify sites in areas more likely to experience a violent event. Of eight high-risk sites identified, two were receptive to hosting a STB course, and one was chosen. Skills, knowledge, and attitudes were assessed precourse and postcourse. Knowledge, attitudes, and real-world tourniquet use were also evaluated at 1-month and 12-months. Results: 15 community members were trained at one community center within an area with a high violent crime rate. As expected, skills improved significantly from precourse to postcourse as did knowledge. Knowledge remained improved at 1-month and 12-months compared with pre-course. Attitudes toward responding to life-threatening bleeding were more positive after the training and remained more positive at follow-up. None of the participants applied a tourniquet within 12-months of the STB course. Conclusions: GIS software can identify STB training sites within high-risk communities with a receptive audience as evidenced by durable knowledge retention and favorable attitudes toward controlling hemorrhage. Future efforts should seek to identify barriers to community training site participation in STB and to further leverage GIS software to identify and train individuals most likely to be present at a life-threatening bleeding event. Level of evidence: Prognostic and Epidemiological, Level III.

  • Open Access

    Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia

    by Anna E. Garcia Whitlock, Jamarie Sostre-Colón, Matthew Gavin, Niels D. Martin, Joseph A. Baur, Carrie A. Sims, Paul M. Titchenell


  • Failure to rescue in surgical patients: A review for acute care surgeons

    by Justin S. Md Hatchimonji, Elinore J. Md Kaufman, Catherine E. Md Sharoky, Lucy Ma, Anna E. Garcia Whitlock, Daniel N. Md Holena

    The Failure to Rescue (FTR) rate is defined as the mortality rate among patients who experience one or more complications. It has been used as an outcome metric for approximately 25 years, primarily in elective surgery populations, and has been shown to be associated with factors that are modifiable on the institutional level. Although the FTR metric was derived in elective surgical populations, modifications have been made in attempts to refine the metric and apply it to broader populations, including medical patients and non-elective surgical patients. However, study among emergency general surgery patients has been limited. In this review, we summarize the current knowledge surrounding FTR, including established risk factors and potential limitations of the metric in emergency general surgery (EGS) populations. We then discuss a conceptual model for FTR events and review strategies to minimize rates. Finally, we provide a brief overview of current areas of study and potential future directions in acute care surgery.


  • Jejunal administration of glucose enhances acyl ghrelin suppression in obese humans

    by Robyn A. Tamboli, Reem M. Sidani, Anna E. Garcia, Joseph Antoun, James M. Isbell, Vance L. Albaugh, Naji N. Abumrad

    Ghrelin is a gastric hormone that stimulates hunger and worsens glucose metabolism. Circulating ghrelin is decreased after Roux-en-Y gastric bypass (RYGB) surgery; however, the mechanism(s) underlying this change is unknown. We tested the hypothesis that jejunal nutrient exposure plays a significant role in ghrelin suppression after RYGB. Feeding tubes were placed in the stomach or jejunum in 13 obese subjects to simulate pre-RYGB or post-RYGB glucose exposure to the gastrointestinal (GI) tract, respectively, without the confounding effects of caloric restriction, weight loss, and surgical stress. On separate study days, the plasma glucose curves obtained with either gastric or jejunal administration of glucose were replicated with intravenous (iv) infusions of glucose. These “isoglycemic clamps” enabled us to determine the contribution of the GI tract and postabsorptive plasma glucose to acyl ghrelin suppression. Plasma acyl ghrelin levels were suppressed to a greater degree with jejunal glucose administration compared with gastric glucose administration (P < 0.05). Jejunal administration of glucose also resulted in a greater suppression of acyl ghrelin than the corresponding isoglycemic glucose infusion (P ≤ 0.01). However, gastric and isoglycemic iv glucose infusions resulted in similar degrees of acyl ghrelin suppression (P > 0.05). Direct exposure of the proximal jejunum to glucose increases acyl ghrelin suppression independent of circulating glucose levels. The enhanced suppression of acyl ghrelin after RYGB may be due to a nutrient-initiated signal in the jejunum that regulates ghrelin secretion.


  • Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4

    by J M Arbones-Mainar, L A Johnson, E Torres-Perez, A E Garcia, S Perez-Diaz, J Raber, N Maeda

    The Apolipoprotein E (APOE) gene encodes for three isoforms in the human population (APOE2, APOE3 and APOE4). Whereas the role of APOE in lipid metabolism is well characterized, the specific metabolic signatures of the APOE isoforms during metabolic disorders, remain unclear. To elucidate the molecular underpinnings of APOE-directed metabolic alterations, we tested the hypothesis that APOE4 drives a whole-body metabolic shift toward increased lipid oxidation. We employed humanized mice in which the Apoe gene has been replaced by the human APOE*3 or APOE*4 allele to produce human APOE3 or APOE4 proteins and characterized several mechanisms of fatty-acid oxidation, lipid storage, substrate utilization and thermogenesis in those mice. We show that, whereas APOE4 mice gained less body weight and mass than their APOE3 counterparts on a Western-type diet (PP=0.004 and P=0.025, respectively). APOE4 mice also demonstrated a reduced respiratory quotient during the postprandial period (0.95±0.03 versus 1.06±0.03, PP=0.039), augmented cold tolerance and more metabolically active brown adipose tissue compared with APOE3 mice. These data suggest that APOE4 mice may resist weight gain via an APOE4-directed global metabolic shift toward lipid oxidation and enhanced thermogenesis, and may represent a critical first step in the development of APOE-directed therapies for a large percentage of the population affected by disorders with established links to APOE and metabolism.


  • Open Access

    Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease

    by Anna E. Garcia, Nader Kasim, Robyn A. Tamboli, Raul S. Gonzalez, Joseph Antoun, Emily A. Eckert, Pamela A. Marks-Shulman, Julia Dunn, Julia Wattacheril, Taylor Wallen, et al.

    Triglyceride content in the liver is regulated by the uptake, production and elimination of lipoproteins, and derangements in these processes contribute to nonalcoholic fatty liver disease (NAFLD). Previous studies show a direct relationship between intrahepatic fat and production of apolipoprotein B100 (apoB100) containing particles, VLDL and LDL, but little consensus exists regarding changes in lipoprotein production in the development of simple steatosis (SS) versus nonalcoholic steatohepatitis (NASH). Further, ethnic variations in lipoproteins among SS and NASH are unknown as is how such variations might contribute to the differential prevalence of disease among Caucasians versus African Americans. In this study, we assessed plasma lipoprotein profiles by nuclear magnetic resonance (NMR) spectroscopy in 70 non-diabetic class III obese females recruited from the surgical weight loss clinic. Of these, 51 females were stratified by biopsy-staged NAFLD severity (histologically normal, SS, or NASH). NASH females displayed increased circulating triglycerides and increased VLDL particle number and size relative to those with histologically normal livers, while total and large LDL concentration decreased in SS versus NASH and correlated with increased insulin resistance (via HOMA2-IR). When Caucasian women were examined alone (n = 41), VLDL and triglycerides increased between normal and SS, while total LDL and apoB100 decreased between SS and NASH along with increased insulin resistance. Compared to Caucasians with SS, African American women with SS displayed reduced triglycerides, VLDL, and small LDL and a more favorable small to large HDL ratio despite having increased BMI and HOMA2-IR. These findings suggest that ApoB100 and lipoprotein subclass particle number and size can delineate steatosis from NASH in obese Caucasian females, but should be interpreted with caution in other ethnicities as African Americans with SS display relatively improved lipoprotein profiles. This may reflect variation in the relationship between dyslipidemia and NAFLD progression across gender and ethnicity.


  • Patient Variables Which May Predict Length of Stay and Hospital Costs in Elderly Patients With Hip Fracture

    by Anna E. Bsph Garcia, J. V. Bs Bonnaig, Zachary T. Bs Yoneda, Justin E. Richards, Jesse M. Ehrenfeld, William T. Obremskey, A. Alex Jahangir, Manish K. Sethi

    Objectives: To investigate what factors contribute to increased length of stay (LOS) and increased costs in treatment of elderly patients with hip fractures. Design: Retrospective chart review. Setting: All patients who presented to a large tertiary care center between January 2000 and December 31, 2009. Participants: Charts for all patients older than 60 years who presented with isolated low-energy hip fractures were reviewed. Of the 719 patients identified, 660 were included. Intervention: Patients who underwent operative fixation or hemiarthroplasty secondary to hip fracture were identified using a search of Current Procedural Terminology (CPT) codes search. Main Outcome Measurements: Gender, height, weight, body mass index, length of procedure, American Society of Anesthesiologists (ASA) classification, and medical comorbidities were gathered and compared with LOS and direct daily inpatient hospital cost. Results: No correlation existed between body mass index or specific comorbidities and LOS, but ASA classification was a predictor. For each ASA increase of 1, average LOS increased 2.053 days (P < 0.001). Given total daily cost to the hospital for these patients was $4530, each increase in ASA classification translated to an increase of $9300. Conclusions: ASA classification proved useful in estimating LOS and cost for patients undergoing operative fixation of hip fractures. Because ASA classification and cost are universally collected, this method can be employed in almost any hospital. This highlights a role for ASA classification in preoperative estimation of the elderly patient's cost and a potential advantage for incorporating patient factors in the development of tiered reimbursement models. Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.